NCT00338962View on ClinicalTrials.gov

Naltrexone & SSRI in Alcoholics With Depression/PTSD

PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
AlcoholismDepressionPTSD
Interventions
DRUG

paroxetine

paroxetine (40mg/day)

DRUG

desipramine

200 mg per day

DRUG

Naltrexone

50 mg per day

DRUG

Placebo

placebo

Trial Locations (1)

06516

VA Connecticut Healthcare Systems, West Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT00338962 - Naltrexone & SSRI in Alcoholics With Depression/PTSD | Biotech Hunter | Biotech Hunter